2015 ADX Header

Cambridge Healthtech Institute’s Second Annual
Clinical NGS Assays
Exploring Technical Mechanisms and Medical Utility
August 18-19, 2015 | Capital Hilton | Washington, DC


With more clinical labs consistently turning to next-generation sequencing (NGS) assays, there is an overwhelming need to understand the fundamentals of running, designing, analyzing and validating NGS tests. The Second Annual Clinical NGS Assays will provide attendees with a comprehensive view of the technical considerations for implementing NGS assays as well as showcase best practices. Regulatory issues specific to NGS such as CLIA accreditation and FDA clearance will also be addressed from both the academic lab and commercial lab perspective. Finally, the clinical potential for NGS technologies will be explored by both physicians and research scientists, providing future directions for successful implementation.

Preliminary Agenda


NGS ASSAY VALIDATION AND ANALYSIS 

Genome in a Bottle: So You've Sequenced a Genome – How Well Did You Do?

Speaker to be Announced, NIST

From Gene Panels to Exome Sequencing - Validation and Implementation of NGS Assays in the Clinic

Birgit Funke, Ph.D., FACMG, Associate Professor, Pathology, Massachusetts General Hospital and Harvard Medical School


NGS PLATFORMS FOR TRANSLATIONAL MEDICINE  

Clinical Laboratory Standards for Next-Generation Sequencing

Pinar Bayrak-Toydemir, M.D., Ph.D., FACMG, Associate Professor, Department of Pathology, University of Utah; Medical Director, Molecular Genetics and Genomics, ARUP Laboratories

Novel Targeted NGS Test for Retinal Dystrophy Empowers Precision Medicine

John Chiang, Ph.D., FACMG, Director, Casey Molecular Diagnostics Laboratory, Oregon Health and Science University

Enrolling Patients in Clinical Trials Based on NGS Data

P. Mickey Williams, Ph.D. (contractor), Director, Molecular Characterization Laboratory (aka MoCha), Frederick National Laboratory for Cancer Research


TRANSLATIONAL STRATEGIES AND CASE STUDIES  

Utility of Implementing Clinical NGS Assays as Standard of Care in Oncology

Helen Fernandes, Ph.D., Director, Molecular Pathology, Pathology & Laboratory Medicine, Weill Cornell Medical College

Development and Implementation of Clinical NGS Testing: Assay Development and Informatic Challenges

Robert D. Daber, Ph.D., Director, Research and Development and Sequencing Operations, Bio-Reference Laboratories

The Medical Exome and Constitutional NGS Studies

Avni B. Santani, Ph.D., Assistant Professor, Clinical Pathology, University of Pennsylvania School of Medicine; Scientific Director, Molecular Genetics Laboratory, The Children's Hospital of Philadelphia



For more details on the conference, please contact:
Samantha Lewis
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: slewis@healthtech.com 

For exhibit & sponsorship opportunities, please contact:
Joe Vacca
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5431
E: jvacca@healthtech.com 

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

2014 Brochure

2014 Brochure 


Premier Sponsor

ThermoFisher Scientific logo 


Related Products

MDX_Logo_150x150